Next Article in Journal
Assessment of Hepatoprotective Effect of Chokeberry Juice in Rats Treated Chronically with Carbon Tetrachloride
Next Article in Special Issue
Antimicrobial and Antioxidant Properties of Four Lycopus Taxa and an Interaction Study of Their Major Compounds
Previous Article in Journal
Special Issue: Development of Asymmetric Synthesis
Previous Article in Special Issue
Enhancement of Macarpine Production in Eschscholzia Californica Suspension Cultures under Salicylic Acid Elicitation and Precursor Supplementation
Review

Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease

1
Department of Pharmacy, Southeast University, Dhaka 1213, Bangladesh
2
Pharmakon Neuroscience Research Network, Dhaka 1207, Bangladesh
3
Department of Pharmacy, BRAC University, Dhaka 1212, Bangladesh
4
Department of Pharmacology and Toxicology, Faculty of Bio-Sciences, Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur 63100, Pakistan
5
Research Unit, Induced Resistance and Plant Bioprotection, EA 4707, SFR Condorcet FR CNRS 3417, Faculty of Sciences, University of Reims Champagne-Ardenne, PO Box 1039, 51687 Reims CEDEX 2, France
6
Division of Drug Design and Medicinal Chemistry Research Lab, Department of Pharmaceutical Chemistry, Ahalia School of Pharmacy, Palakkad, Kerala 678557, India
7
Department of Chemistry, University of Swabi, Anbar 23561, Khyber Pakhtunkhwa, Pakistan
8
Department of Bioresources and Food Sciences, Konkuk University, Seoul 05029, Korea
9
Instituto de Investigación e Innovación en Salud, Facultad de Ciencias de la Salud, Universidad Central de Chile, Santiago 8330507, Chile
10
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
11
King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
12
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia
13
Chrono-Environnement Laboratory, UMR CNRS 6249, Bourgogne Franche-Comté University, F-25030 Besançon, France
*
Authors to whom correspondence should be addressed.
Molecules 2020, 25(6), 1267; https://doi.org/10.3390/molecules25061267
Received: 6 February 2020 / Revised: 5 March 2020 / Accepted: 10 March 2020 / Published: 11 March 2020
(This article belongs to the Special Issue Bioactive Natural Compounds and Their Mechanisms of Action)
Alzheimer’s disease (AD) is one of the utmost chronic neurodegenerative disorders, which is characterized from a neuropathological point of view by the aggregates of amyloid beta (Aβ) peptides that are deposited as senile plaques and tau proteins which form neurofibrillary tangles (NFTs). Even though advancement has been observed in order to understand AD pathogenesis, currently available therapeutic methods can only deliver modest symptomatic relief. Interestingly, naturally occurring dietary flavonoids have gained substantial attention due to their antioxidative, anti-inflammatory, and anti-amyloidogenic properties as alternative candidates for AD therapy. Experimental proof provides support to the idea that some flavonoids might protect AD by interfering with the production and aggregation of Aβ peptides and/or decreasing the aggregation of tau. Flavonoids have the ability to promote clearance of Aβ peptides and inhibit tau phosphorylation by the mTOR/autophagy signaling pathway. Moreover, due to their cholinesterase inhibitory potential, flavonoids can represent promising symptomatic anti-Alzheimer agents. Several processes have been suggested for the aptitude of flavonoids to slow down the advancement or to avert the onset of Alzheimer’s pathogenesis. To enhance cognitive performance and to prevent the onset and progress of AD, the interaction of flavonoids with various signaling pathways is proposed to exert their therapeutic potential. Therefore, this review elaborates on the probable therapeutic approaches of flavonoids aimed at averting or slowing the progression of the AD pathogenesis. View Full-Text
Keywords: Alzheimer’s disease; flavonoids; amyloid plaque; neurofibrillary tangles; PI3K/Akt signaling; MAPK signaling; mTOR Alzheimer’s disease; flavonoids; amyloid plaque; neurofibrillary tangles; PI3K/Akt signaling; MAPK signaling; mTOR
Show Figures

Graphical abstract

MDPI and ACS Style

Uddin, M.S.; Kabir, M.T.; Niaz, K.; Jeandet, P.; Clément, C.; Mathew, B.; Rauf, A.; Rengasamy, K.R.R.; Sobarzo-Sánchez, E.; Ashraf, G.M.; Aleya, L. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease. Molecules 2020, 25, 1267. https://doi.org/10.3390/molecules25061267

AMA Style

Uddin MS, Kabir MT, Niaz K, Jeandet P, Clément C, Mathew B, Rauf A, Rengasamy KRR, Sobarzo-Sánchez E, Ashraf GM, Aleya L. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease. Molecules. 2020; 25(6):1267. https://doi.org/10.3390/molecules25061267

Chicago/Turabian Style

Uddin, Md. S., Md. T. Kabir, Kamal Niaz, Philippe Jeandet, Christophe Clément, Bijo Mathew, Abdur Rauf, Kannan R.R. Rengasamy, Eduardo Sobarzo-Sánchez, Ghulam M. Ashraf, and Lotfi Aleya. 2020. "Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease" Molecules 25, no. 6: 1267. https://doi.org/10.3390/molecules25061267

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop